BiomeSense

BiomeSense is developing a fully automated biosensor for low-cost, scalable microbiome testing. The device will solve the cost and patient adherence problems with current testing methods, making longitudinal sampling routine.…

AVnovum

AVnovum is developing a new class of antimicrobial therapy, AVpeptides, that maintain healthy fungal microbiomes by preventing virulence and infection. AVpeptides work through mechanisms that specifically target virulent but not…

Oxalo Therapeutics

Oxalo Therapeutics is developing first-in-class therapeutics to treat rare renal diseases and prevent recurrent kidney stones. University of Chicago assistant professor of medicine Hatim Hassan, MD, PhD, studies kidney disease…

Seurat Therapeutics

Seurat Therapeutics is based on years of research by Richard Kraig, MD, PhD, at the University of Chicago that targets a naturally-derived cure for migraines aimed at the root cause…

ClostraBio

ClostraBio is dedicated to understanding and treating food allergies and other disease of the immune system. Founded in 2016 by Cathryn R. Nagler, PhD and Jeffrey A. Hubbell, PhD, ColstraBio…

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept